NewAmsterdam Pharma Company NV (NASDAQ: NAMS) flaunted slowness of -1.39% at $23.37, before settling in for the price of $23.70 at the close. Taking a more long-term approach, NAMS posted a 52-week range of $15.19-$27.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -28.76%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.52%. This publicly-traded company’s shares outstanding now amounts to $92.17 million, simultaneously with a float of $60.55 million. The organization now has a market capitalization sitting at $2.50 billion. At the time of writing, stock’s 50-day Moving Average stood at $23.60, while the 200-day Moving Average is $19.82.
NewAmsterdam Pharma Company NV (NAMS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the NewAmsterdam Pharma Company NV industry. NewAmsterdam Pharma Company NV’s current insider ownership accounts for 43.32%, in contrast to 35.60% institutional ownership. Preceding that transaction, on Dec 30 ’24, Company’s 10% Owner sold 29,846 for 25.54, making the whole transaction’s value amount to 762,174. This particular insider is now the holder of 10,656,172 in total.
NewAmsterdam Pharma Company NV (NAMS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
NewAmsterdam Pharma Company NV’s EPS increase for this current 12-month fiscal period is 5.52% and is forecasted to reach -1.81 in the upcoming year.
NewAmsterdam Pharma Company NV (NASDAQ: NAMS) Trading Performance Indicators
Let’s observe the current performance indicators for NewAmsterdam Pharma Company NV (NAMS). It’s Quick Ratio in the last reported quarter now stands at 10.61. The Stock has managed to achieve an average true range (ATR) of 1.12.
Technical Analysis of NewAmsterdam Pharma Company NV (NAMS)
Now, what If we examine the latest scores posted by [NewAmsterdam Pharma Company NV, NAMS]. During the last 5-days, its volume was better the volume of 0.61 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 24.81% While, its Average True Range was 1.03.
Raw Stochastic average of NewAmsterdam Pharma Company NV (NAMS) in the period of the previous 100 days is set at 67.60%, which indicates a major rise in contrast to 19.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 23.71% that was lower than 75.78% volatility it exhibited in the past 100-days period.
